Aggregation and fusion of low-density lipoproteins in vivo and in vitro

Biomolecular Concepts

Volumn 4, Issue 5, 2013, Pages 501-518

  Lu, Mengxiao ^a   Gursky, Olga ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

And mechanical denaturation; Chemical; Early events in atherosclerosis; Hydrophobic interactions; Lipoprotein hydrolysis; Low density lipoprotein (LDL) fusion kinetics; Thermal

Indexed keywords

APOLIPOPROTEIN B; CERAMIDE; ESTRADIOL; FATTY ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN;

ATHEROSCLEROSIS; CHEMISTRY; GENETICS; HUMAN; MECHANICAL STRESS; METABOLISM; PATHOLOGY;

APOLIPOPROTEINS B; ATHEROSCLEROSIS; CERAMIDES; ESTRADIOL; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; SERUM ALBUMIN; STRESS, MECHANICAL;

EID: 84888601992     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2013-0016     Document Type: Review

References (136)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics -2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-220.
2. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992; 2: 23-8.
3. Driscoll DM, Getz GS. Molecular and cell biology of lipoprotein biosynthesis. Methods Enzymol 1986; 128: 41-70.
4. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985; 1: 1-39.
5. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol 2009; 29: 431-8.
6. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 1981; 78: 6499-503.
7. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994; 63: 601-37.
8. Williams KJ, Tabas I. The response-To-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-61.
9. Tirziu D, Dobrian A, Tasca C, Simionescu M, Simionescu N. Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis 1995; 112: 101-14.
10. Guyton JR, Klemp KF, Black BL, Bocan TM. Extracellular lipid deposition in atherosclerosis. Eur Heart J 1990; 11: 20-8.
11. Oorni K, Pentikainen MO, Ala-Korpela M, Kovanen PT. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res 2000; 41: 1703-14.
12. Nievelstein PF, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb 1991; 11: 1795-805.
13. Nievelstein-Post P, Mottino G, Fogelman A, Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb 1994; 14: 1151-61.
14. Hurt-Camejo E, Camejo G, Sartipy P. Phospholipase A2 and small, dense low-density lipoprotein. Curr Opin Lipidol 2000; 11: 465-71.
15. Guyton Jr. The arterial wall and the atherosclerotic lesion. Curr Opin Lipidol 1994; 5: 376-81.
16. Bancells C, Villegas S, Blanco FJ, Benitez S, Gallego I, Beloki L, Perez-Cuellar M, Ordonez-Llanos J, Sanchez-Quesada JL. Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem 2010; 285: 32425-35.
17. Paananen K, Saarinen J, Annila A, Kovanen PT. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans. J Biol Chem 1995; 270: 12257-62.
18. Pentikainen MO, Lehtonen EM, Kovanen PT. Aggregation and fusion of modified low density lipoprotein. J Lipid Res 1996; 37: 2638-49.
19. Parasassi T, De Spirito M, Mei G, Brunelli R, Greco G, Lenzi L, Maulucci G, Nicolai E, Papi M, Arcovito G, Tosatto SC, Ursini F. Low density lipoprotein misfolding and amyloidogenesis. FASEB J 2008; 22: 2350-6.
20. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998; 139: 205-22.
21. Hoff HF, Morton RE. Lipoproteins containing apo B extracted from human aortas. Structure and function. Ann NY Acad Sci 1985; 454: 183-94.
22. Aviram M, Maor I, Keidar S, Hayek T, Oiknine J, Bar-El Y, Adler Z, Kertzman V, Milo S. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem Biophys Res Commun 1995; 216: 501-13.
23. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res 1989; 30: 967-78.
24. Steinbrecher UP, Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb 1992; 12: 608-25.
25. Llorente-Cortes V, Badimon L. LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler Thromb Vasc Biol 2005; 25: 497-504.
26. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333-7.
27. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-Aggregation. Arteriosclerosis 1988; 8: 348-58.
28. Jayaraman S, Gantz D, Gursky O. Structural basis for thermal stability of human low-density lipoprotein. Biochemistry 2005; 44: 3965-71.
29. Lu M, Gantz DL, Herscovitz H, Gursky O. Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis. J Lipid Res 2012; 53: 2175-85.
30. Marathe S, Kuriakose G, Williams KJ, Tabas I. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler Thromb Vasc Biol 1999; 19: 2648-58.
31. Nelson GJ, Freeman NK. The phospholipid and phospholipid fatty acid composition of human serum lipoprotein fractions. J Biol Chem 1960; 235: 578-83.
32. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455-64.
33. Oorni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem 1998; 273: 29127-34.
34. Corson MA. Emerging inflammatory markers for assessing coronary heart disease risk. Curr Cardiol Rep 2009; 11: 452-9.
35. Jonsson-Rylander AC, Lundin S, Rosengren B, Pettersson C, Hurt-Camejo E. Role of secretory phospholipases in atherogenesis. Curr Atheroscler Rep 2008; 10: 252-9.
36. Davis B, Koster G, Douet LJ, Scigelova M, Woffendin G, Ward JM, Smith A, Humphries J, Burnand KG, Macphee CH, Postle AD. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-Associated phospholipase A2 in oxidized human low density lipoprotein. J Biol Chem 2008; 283: 6428-37.
37. Jayaraman S, Gantz DL, Gursky O. Effects of phospholipase A(2) and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid droplets. J Lipid Res 2011; 52: 549-57.
38. Hakala JK, Oorni K, Pentikainen MO, Hurt-Camejo E, Kovanen PT. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans. Arterioscler Thromb Vasc Biol 2001; 21: 1053-8.
39. Suits AG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci USA 1989; 86: 2713-7.
40. Sanchez-Quesada JL, Villegas S, Ordonez-Llanos J. Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding. Curr Opin Lipidol 2012; 23: 479-86.
41. Khoo JC, Miller E, McLoughlin P, Steinberg D. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res 1990; 31: 645-52.
42. Kruth HS. Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development. Atherosclerosis 1985; 57: 337-41.
43. Chao FF, Blanchette-Mackie EJ, Tertov VV, Skarlatos SI, Chen YJ, Kruth HS. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem 1992; 267: 4992-8.
44. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002; 80: 753-69.
45. Musliner TA, Long MD, Forte TM, Nichols AV, Gong EL, Blanche PJ, Krauss RM. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. J Lipid Res 1991; 32: 917-33.
46. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
47. Auerbach BJ, Bisgaier CL, Wolle J, Saxena U. Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix. J Biol Chem 1996; 271: 1329-35.
48. Pentikainen MO, Oorni K, Kovanen PT. Lipoprotein lipase (LPL) strongly links native and oxidized low density lipoprotein particles to decorin-coated collagen. Roles for both dimeric and monomeric forms of LPL. J Biol Chem 2000; 275: 5694-701.
49. Walters MJ, Wrenn SP. Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation. J Colloid Interface Sci 2011; 363: 268-74.
50. McNamara JR, Small DM, Li Z, Schaefer EJ. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res 1996; 37: 1924-35.
51. Kovanen PT, Kokkonen JO. Modification of low density lipoproteins by secretory granules of rat serosal mast cells. J Biol Chem 1991; 266: 4430-6.
52. Piha M, Lindstedt L, Kovanen PT. Fusion of proteolyzed low-density lipoprotein in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry 1995; 34: 10120-9.
53. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983; 24: 1070-6.
54. Henriksen T, Evensen SA, Carlander B. Injury to cultured endothelial cells induced by low density lipoproteins: protection by high density lipoproteins. Scand J Clin Lab Invest 1979; 39: 369-75.
55. Hessler JR, Robertson AL Jr, Chisolm GM 3rd. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979; 32: 213-29.
56. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983; 3: 215-22.
57. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149-59.
58. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-7.
59. Jurgens G, Hoff HF, Chisolm GM 3rd, Esterbauer H. Modification of human serum low density lipoprotein by oxidation -characterization and pathophysiological implications. Chem Phys Lipids 1987; 45: 315-36.
60. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 1997; 8: 268-74.
61. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
62. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478.
63. Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL. Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004; 110: 637-41.
64. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009; 50: S376-81.
65. Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 2311-6.
66. Yoshida H, Kisugi R. Mechanisms of LDL oxidation. Clin Chim Acta 2010; 411: 1875-82.
67. Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb 1991; 11: 1209-22.
68. Hoff HF, Whitaker TE, O'Neil J. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. J Biol Chem 1992; 267: 602-9.
69. Cynshi O, Takashima Y, Suzuki T, Kawabe Y, Ohba Y, Kodama T. Characterization of aggregated low density lipoproteins induced by copper-catalyzed oxidation. J Atheroscler Thromb 1994; 1: 87-97.
70. Dobrian A, Mora R, Simionescu M, Simionescu N. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. Biochim Biophys Acta 1993; 1169: 12-24.
71. Jayaraman S, Gantz DL, Gursky O. Effects of oxidation on the structure and stability of human low-density lipoprotein. Biochemistry 2007; 46: 5790-7.
72. Meyer DF, Nealis AS, Macphee CH, Groot PH, Suckling KE, Bruckdorfer KR, Perkins SJ. Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition. Biochem J 1996; 319: 217-27.
73. Ettelaie C, Haris PI, James NJ, Wilbourn B, Adam JM, Bruckdorfer KR. Alterations in the structure of apolipoprotein B-100 determine the behaviour of LDL towards thromboplastin. Biochim Biophys Acta 1997; 1345: 237-47.
74. Soran H, Durrington PN. Susceptibility of LDL and its subfractions to glycation. Curr Opin Lipidol 2011; 22: 254-61.
75. Younis N, Sharma R, Soran H, Charlton-Menys V, Elseweidy M, Durrington PN. Glycation as an atherogenic modification of LDL. Curr Opin Lipidol 2008; 19: 378-84.
76. Younis N, Charlton-Menys V, Sharma R, Soran H, Durrington PN. Glycation of LDL in non-diabetic people: small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis 2009; 202: 162-8.
77. Steinbrecher UP, Witztum JL. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984; 33: 130-4.
78. Schleicher E, Deufel T, Wieland OH. Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients. FEBS Lett 1981; 129: 1-4.
79. Younis NN, Soran H, Sharma R, Charlton-Menys V, Greenstein A, Elseweidy MM, Durrington PN. Small-dense LDL and LDL glycation in metabolic syndrome and in statin-Treated and non-statin-Treated type 2 diabetes. Diab Vasc Dis Res 2010; 7: 289-95.
80. Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu Rev Nutr 1999; 19: 123-39.
81. Eckey R, Menschikowski M, Lattke P, Jaross W. Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2. Atherosclerosis 1997; 132: 165-76.
82. De Spirito M, Brunelli R, Mei G, Bertani FR, Ciasca G, Greco G, Papi M, Arcovito G, Ursini F, Parasassi T. Low density lipoprotein aged in plasma forms clusters resembling subendothelial droplets: aggregation via surface sites. Biophys J 2006; 90: 4239-47.
83. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun 1989; 163: 489-94.
84. Mahley RW, Innerarity TL, Weisgraber KB, Oh SY. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J Clin Invest 1979; 64: 743-50.
85. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980; 77: 2214-8.
86. Shechter I, Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards PA. The metabolism of native and malondialdehyde-Altered low density lipoproteins by human monocyte-macrophages. J Lipid Res 1981; 22: 63-71.
87. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 1989; 162: 206-11.
88. Rankin SM, de Whalley CV, Hoult JR, Jessup W, Wilkins GM, Collard J, Leake DS. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem Pharmacol 1993; 45: 67-75.
89. Walters MJ, Wrenn SP. Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein. Langmuir 2008; 24: 9642-7.
90. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000; 28: 1815-26.
91. de Winther MP, Hofker MH. Scavenging new insights into atherogenesis. J Clin Invest 2000; 105: 1039-41.
92. Zhang WY, Schwartz E, Wang Y, Attrep J, Li Z, Reaven P. Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 514-9.
93. Chernomordik L. Non-bilayer lipids and biological fusion intermediates. Chem Phys Lipids 1996; 81: 203-13.
94. Kantor HL, Prestegard JH. Fusion of phosphatidylcholine bilayer vesicles: role of free fatty acid. Biochemistry 1978; 17: 3592-7.
95. Lahdesmaki K, Plihtari R, Soininen P, Hurt-Camejo E, Ala-Korpela M, Oorni K, Kovanen PT. Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH. Atherosclerosis 2009; 207: 352-9.
96. Talbot RM, del Rio JD, Weinberg PD. Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL. J Lipid Res 2003; 44: 837-45.
97. Talbot RM, del Rio JD, Leake DS, Weinberg PD. Oxidation affects the flow-induced aggregation of low density lipoprotein and its inhibition by albumin. Biochim Biophys Acta 2003; 1634: 24-9.
98. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, Anantharamaiah GM. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 1992; 33: 141-66.
99. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
100. Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High -Density Lipoprotein Intervention Trial. Am J Cardiol 2000; 86: 19L-22L.
101. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-28.
102. von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001; 21: 13-27.
103. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
104. Liu H, Scraba DG, Ryan RO. Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett 1993; 316: 27-33.
105. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 76: 4-12.
106. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 199-210.
107. Sack MN, Rader DJ, Cannon RO 3rd. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-70.
108. Shwaery GT, Vita JA, Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of 17 beta-estradiol. Requirement for estradiol modification. Circulation 1997; 95: 1378-85.
109. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun 1990; 8: 167-73.
110. Brunelli R, Mei G, Krasnowska EK, Pierucci F, Zichella L, Ursini F, Parasassi T. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation. Biochemistry 2000; 39: 13897-903.
111. Melnichenko AA, Aksenov DV, Myasoedova VA, Panasenko OM, Yaroslavov AA, Sobenin IA, Bobryshev YV, Orekhov AN. Pluronic block copolymers inhibit low density lipoprotein self-Association. Lipids 2012; 47: 995-1000.
112. Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008; 130: 98-106.
113. Lentz BR. PEG as a tool to gain insight into membrane fusion. Eur Biophys J 2007; 36: 315-26.
114. Jayaraman S, Gantz DL, Gursky O. Poly(ethylene glycol)-induced fusion and destabilization of human plasma high-density lipoproteins. Biochemistry 2004; 43: 5520-31.
115. Mehta R, Gantz DL, Gursky O. Human plasma high-density lipoproteins are stabilized by kinetic factors. J Mol Biol 2003; 328: 183-92.
116. Guha M, England C, Herscovitz H, Gursky O. Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles. Biochemistry 2007; 46: 6043-9.
117. Naghavi M, John R, Naguib S, Siadaty MS, Grasu R, Kurian KC, van Winkle WB, Soller B, Litovsky S, Madjid M, Willerson JT, Casscells W. pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis 2002; 164: 27-35.
118. Oorni K, Kovanen PT. Enhanced extracellular lipid accumulation in acidic environments. Curr Opin Lipidol 2006; 17: 534-40.
119. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006; 69: 625-35.
120. Schissel SL, Schuchman EH, Williams KJ, Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 1996; 271: 18431-6.
121. Shamir R, Johnson WJ, Morlock-Fitzpatrick K, Zolfaghari R, Li L, Mas E, Lombardo D, Morel DW, Fisher EA. Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitro. J Clin Invest 1996; 97: 1696-704.
122. Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple method for quantification of small, dense LDL. J Lipid Res 2003; 44: 2193-201.
123. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem 2010; 56: 967-76.
124. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992; 85: 37-45.
125. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
126. Chappell DA, Fry GL, Waknitz MA, Berns JJ. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding. J Biol Chem 1991; 266: 19296-302.
127. Zhang L, Song J, Cavigiolio G, Ishida BY, Zhang S, Kane JP, Weisgraber KH, Oda MN, Rye KA, Pownall HJ, Ren G. Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J Lipid Res 2011; 52: 175-84.
128. Liu Y, Atkinson D. Enhancing the contrast of ApoB to locate the surface components in the 3D density map of human LDL. J Mol Biol 2011; 405: 274-83.
129. Kumar V, Butcher SJ, Oorni K, Engelhardt P, Heikkonen J, Kaski K, Ala-Korpela M, Kovanen PT. Three-dimensional cryoEM reconstruction of native LDL particles to 16A resolution at physiological body temperature. PLoS One 2011; 6: e18841.
130. Ala-Korpela M, Pentikainen MO, Korhonen A, Hevonoja T, Lounila J, Kovanen PT. Detection of low density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy. J Lipid Res 1998; 39: 1705-12.
131. Lounila J, Ala-Korpela M, Jokisaari J, Savolainen MJ, Kesaniemi YA. Effects of orientational order and particle size on the NMR line positions of lipoproteins. Phys Rev Lett 1994; 72: 4049-52.
132. Pentikainen MO, Lehtonen EM, Oorni K, Lusa S, Somerharju P, Jauhiainen M, Kovanen PT. Human arterial proteoglycans increase the rate of proteolytic fusion of low density lipoprotein particles. J Biol Chem 1997; 272: 25283-8.
133. Fu D, Lu FK, Zhang X, Freudiger C, Pernik DR, Holtom G, Xie XS. Quantitative chemical imaging with multiplex stimulated Raman scattering microscopy. J Am Chem Soc 2012; 134: 3623-6.
134. Benjwal S, Verma S, Rohm KH, Gursky O. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci 2006; 15: 635-9.
135. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978; 75: 3327-31.
136. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. J Am Med Assoc 2004; 291: 210-5.